News & Blogs

Werfen has completed the acquisition of Omixon, a privately held company based in Budapest, Hungary, focused on the development and commercialization of Next Generation Sequencing (NGS) technologies in transplant diagnostics. The acquisition expands Werfen’s portfolio of transplant diagnostics solutions for […]

You deserve exceptional service/support and our NEW Customer Center is a testament to our commitment to your satisfaction. This innovative platform serves as a hub where you can access a wide range of resources, tools, and services to enhance your […]

WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and […]

Immucor se dedica a apoyar a nuestras comunidades y entornos globales y locales mediante la donación de nuestro tiempo, talento y dinero con el fin de transformar una vida. El Resultado es un Cambio de Vida. Con sedes repartidas por […]